HO-1, as an anti-oxidative and anti-inflammation factor, has been proven to have lipid metabolic benefit in diabetic and non-alcoholic fatty liver disease (NAFLD) rodent model (34, 44–46). The gene discussed is HMOX1; the disease is metabolic dysfunction-associated steatotic liver disease.